Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed2
Recruiting1

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT04008121Early Phase 1Recruiting
Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
Diabetic RetinopathyMacular DegenerationRetinal Vein Occlusion+1 more
StudydirectorStart date: 2025-11-06
NCT03962998Early Phase 1Completed
Oral Administration of MB-102 Versus Dual Sugar Testing for Gut Permeability
Crohn Disease
StudydirectorStart date: 2019-10-27
NCT03810833Not ApplicableCompleted
Tolerability and Background Fluorescence of the MediBeacon Transdermal GFR Measurement System
Acute Kidney Injury
StudydirectorStart date: 2019-09-16

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04008121Early Phase 1StudyDirector

Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium

Diabetic RetinopathyMacular DegenerationRetinal Vein Occlusion+1 more
Recruiting
NCT03962998Early Phase 1StudyDirector

Oral Administration of MB-102 Versus Dual Sugar Testing for Gut Permeability

Crohn Disease
Completed
NCT03810833Not ApplicableStudyDirector

Tolerability and Background Fluorescence of the MediBeacon Transdermal GFR Measurement System

Acute Kidney Injury
Completed

All 3 trials loaded